ライフサイエンスコーパス: lymphoscintigraphy

1 of the terms cervical cancer, SPECT/CT, and lymphoscintigraphy.

2 mities), while they were not detectable with lymphoscintigraphy.

3 ugh imaging, including indirect radionuclide lymphoscintigraphy.

4 lymphatic US compared favorably with that at lymphoscintigraphy.

5 within the SLN, which was not possible with lymphoscintigraphy.

6 is properly diagnosed and characterized with lymphoscintigraphy.

7 rall SLN detection in comparison with planar lymphoscintigraphy.

8 biopsy type; and interval between biopsy and lymphoscintigraphy.

9 issection to be performed on the same day as lymphoscintigraphy.

10 albumin (HSA) with SLN biopsy after SC-based lymphoscintigraphy.

11 lling in a 23-yr-old man was investigated by lymphoscintigraphy.

12 ine (73%) of the 136 SLNs were visualized at lymphoscintigraphy; 30 (81%) of the 37 nonvisualized SLN

13 were seen in studies that used preoperative lymphoscintigraphy and dual mapping during surgery.

14 tinuity and function were demonstrable using lymphoscintigraphy and fluorescence microlymphangiograph

15 All underwent preoperative lymphoscintigraphy and intraoperative lymphatic mapping

16 Preoperative lymphoscintigraphy and intraoperative lymphatic mapping

17 ng intradermal hybrid tracer administration, lymphoscintigraphy and single photon emission computed t

18 ics is further hindered by the resolution of lymphoscintigraphy and SPECT.

19 nventional imaging techniques such as planar lymphoscintigraphy and SPECT/CT, preoperative sentinel n

20 cation of the SNs identified on preoperative lymphoscintigraphy and SPECT/CT.

21 went SLN dissection directed by preoperative lymphoscintigraphy and vital blue dye mapping; in the re

22 ing magnetic resonance, computed tomography, lymphoscintigraphy, and emerging optical techniques with

23 of lymphatic function demonstrated by serial lymphoscintigraphy, and finally, attenuation of the fibr

24 8, 20 patients underwent Tc99 sulfur colloid lymphoscintigraphy, and SLNB was performed with use of a

25 who had breast cancer underwent preoperative lymphoscintigraphy before SLN biopsy.

26 With lymphoscintigraphy, better visualization of inguinal lym

27 dies including optical coherence tomography, lymphoscintigraphy, brain magnetic resonance and nuclear

28 ll three agents are acceptable for cutaneous lymphoscintigraphy, but reliable identification of senti

29 This study provides proof of principle for lymphoscintigraphy by receptor-mediated delivery of a no

30 Preoperative lymphoscintigraphy can identify all regional nodal basin

31 Beyond lymphoscintigraphy, clinically-relevant imaging modaliti

32 Weak lymphatic drainage at lymphoscintigraphy correlated with lymphangiectasia at M

33 Postoperative lymphoscintigraphy demonstrated at least some improvemen

34 Lymphatic US depicted 28 SLNs, while lymphoscintigraphy depicted 27 "hot spots" suspected of

35 iologic principles of lymphatic imaging with lymphoscintigraphy, discuss different qualitative and qu

36 Preoperative lymphoscintigraphy does not improve the ability to ident

37 ere correlated with corresponding results of lymphoscintigraphy examinations.

38 ion of inguinal lymph nodes was clearer with lymphoscintigraphy (five of 60 extremities).

39 There has been a resurgence in the use of lymphoscintigraphy for the external detection of lymph n

40 ern of tumor lymphatic drainage and the SLN, lymphoscintigraphy has been performed using primarily 99

41 Lymphoscintigraphy has many advantages over contrast lym

42 in breast cancer patients using preoperative lymphoscintigraphy have been reported.

43 ymphatic basins and nodes were identified by lymphoscintigraphy in all patients.

44 Data from preoperative lymphoscintigraphy, intraoperative lymphatic mapping, op

45 tic biopsy type; interval between biopsy and lymphoscintigraphy; intraoperative identification method

46 Lymphoscintigraphy is a useful technique for the evaluat

47 Lymphoscintigraphy is an important part of the mapping a

48 Although lymphoscintigraphy is commonly used for the preoperative

49 Lymphoscintigraphy is highly reproducible in the detecti

50 etary radiolabeled nanocolloid indicated for lymphoscintigraphy is not available, prostate lymph node

51 Routine preoperative lymphoscintigraphy is not necessary for the identificati

52 Lymphoscintigraphy is reproducible in detection of the s

53 Preoperative injection of Tc99 and lymphoscintigraphy is standardly performed before sentin

54 An important use of lymphoscintigraphy is to evaluate extremity edema.

55 ese models over time, both systemically with lymphoscintigraphy (LS) and locally using fluorescence m

56 All had preoperative lymphoscintigraphy (LSG) and SLN biopsy using both blue

57 retrospective study was to determine whether lymphoscintigraphy (LSG) for sentinel lymph node (SNL) m

58 benefit of IMN irradiation become available, lymphoscintigraphy may be used to help guide decisions r

59 PET/CT lymphoscintigraphy may improve the detection and localiz

60 Notably, this approach parallels the current lymphoscintigraphy method but enables the direct PET vis

61 We aimed to compare SPECT/CT and lymphoscintigraphy on overall and bilateral sentinel lym

62 acement of 125I seeds did not interfere with lymphoscintigraphy or intraoperative identification of S

63 31) for lymphatic US and 81% (25 of 31) for lymphoscintigraphy (P =.29).

64 tudy was to determine the reproducibility of lymphoscintigraphy performed by different team members f

65 the additional value of SPECT/CT over planar lymphoscintigraphy (PI) in sentinel node (SN) detection

66 SPECT/CT (range, 62.7%-79.3%) and 66.7% for lymphoscintigraphy (range, 56.9%-75.8%), yielding a pool

67 SPECT/CT (range, 92.2%-100.0%) and 85.3% for lymphoscintigraphy (range, 70.0%-100.0%).

68 Preoperative lymphoscintigraphy revealed at least one sentinel node i

69 Imaging findings of MR lymphangiography and lymphoscintigraphy show a clear concordance.

70 Lower limb lymphoscintigraphy showed features of an unusual lymphat

71 Recently, lymphoscintigraphy studies have renewed interest in IMN

72 All underwent 2 separate lymphoscintigraphy studies, which followed the same acqu

73 percent of patients showed 1-3 SLNs in both lymphoscintigraphy studies.

74 tate has proved to be an excellent agent for lymphoscintigraphy studies.

75 68 patients (96%), the findings of the first lymphoscintigraphy study were similar to those of the se

76 Lymphatic congestion lymphoscintigraphy thus provided a quantitative measure

77 Effective use of lymphoscintigraphy to plan therapy requires an understan

78 ssess reproducibility, 13 patients underwent lymphoscintigraphy twice within 2-17 days.

79 Four patients underwent lymphoscintigraphy twice, once with SC and once with HSA

80 In 11 of the 13 who underwent lymphoscintigraphy twice, sentinel node identification w

81 PET/CT study on SN detection indicated that lymphoscintigraphy using (89)Zr-nanocolloidal albumin is

82 is study, the clinical feasibility of PET/CT lymphoscintigraphy using (89)Zr-nanocolloidal albumin wa

83 developed a practice procedure for prostate lymphoscintigraphy using SPECT/CT and filtered (99m)Tc-s

84 Lymphoscintigraphy was also performed.

85 Lymphoscintigraphy was followed by injection of a blue d

86 Lymphoscintigraphy was performed after intradermal injec

87 PET/CT lymphoscintigraphy was performed after peritumoral injec

88 Preoperative lymphoscintigraphy was performed at the discretion of th

89 Preoperative breast lymphoscintigraphy was performed in consecutive breast c

90 Radionuclide lymphoscintigraphy was performed to quantitate lymphatic

91 After injection at the lesion site, lymphoscintigraphy was performed with a 10-min dynamic s

92 sion computed tomography/computed tomography lymphoscintigraphy, we quantified the lymphatic flow ind

93 Five of six nodes not seen with lymphoscintigraphy were detected with lymphatic US.

94 re assigned to one of three groups of 17 for lymphoscintigraphy with one of three radiopharmaceutical

95 n of the sentinel lymph node is preoperative lymphoscintigraphy with technetium Tc 99m.